Free Trial

Advisors Asset Management Inc. Has $5.94 Million Stock Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Advisors Asset Management Inc. increased its stake in The Clorox Company by 12.6%, now holding 40,308 shares worth approximately $5.94 million.
  • Clorox reported a quarterly earnings per share (EPS) of $2.87, exceeding the consensus estimate of $2.24, with a year-over-year revenue increase of 4.5%.
  • The company recently declared a quarterly dividend of $1.24, reflecting an annualized yield of 4.0%, and marking an increase from the previous quarterly dividend of $1.22.
  • MarketBeat previews the top five stocks to own by October 1st.

Advisors Asset Management Inc. grew its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 12.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,308 shares of the company's stock after purchasing an additional 4,505 shares during the quarter. Advisors Asset Management Inc.'s holdings in Clorox were worth $5,935,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in CLX. Raymond James Financial Inc. boosted its position in shares of Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company's stock valued at $39,747,000 after acquiring an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new stake in Clorox in the first quarter worth $247,000. Brown Miller Wealth Management LLC purchased a new position in shares of Clorox during the first quarter valued at $399,000. Roman Butler Fullerton & Co. purchased a new position in shares of Clorox during the first quarter valued at $400,000. Finally, Wedge Capital Management L L P NC grew its stake in Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock valued at $4,198,000 after purchasing an additional 7,159 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Down 0.1%

Shares of CLX traded down $0.11 during midday trading on Tuesday, reaching $125.76. 1,345,194 shares of the company were exchanged, compared to its average volume of 1,672,534. The stock has a 50-day moving average price of $124.28 and a 200-day moving average price of $132.99. The company has a market cap of $15.38 billion, a price-to-earnings ratio of 19.29, a P/E/G ratio of 1.02 and a beta of 0.52. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were paid a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 annualized dividend and a dividend yield of 3.9%. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is 76.07%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Morgan Stanley lowered their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. JPMorgan Chase & Co. upped their price target on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research note on Monday. Citigroup restated a "neutral" rating and set a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. UBS Group dropped their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Finally, Jefferies Financial Group decreased their target price on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Reduce" and a consensus price target of $142.18.

Get Our Latest Research Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.